“School of Cognitive”

Back to Papers Home
Back to Papers of School of Cognitive

Paper   IPM / Cognitive / 7847
School of Cognitive Sciences
  Title:   Repeated administration of dopaminergic agents in the dorsal hippocampus and morphine-induced place preference
  Author(s): 
1.  M.R. Zarrindast
2.  M. Nasehi
3.  P. Rostami
4.  A. Rezayof
5.  S. Fazli-Tabaei
  Status:   Published
  Journal: Behavioral Pharmacology
  No.:  2
  Vol.:  16
  Year:  2005
  Pages:   85-92
  Supported by:  IPM
  Abstract:
A Department of Pharmacology and Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran bSchool of Cognitive Science, Institute for Studies in Theoretical Physics and Mathematics, Tehran, Iran cDepartment of Biology, Teacher Training University, Tehran, Iran dDepartment of Biology, Faculty of Science, Tehran University, Tehran, Iran eDepartment of Physiology, Tehran Medical Unit, Azad University, Tehran, Iran. The aim of the present experiments was to investigate whether repeated intra-hippocampal CA1 (intra-CA1) administration of dopaminergic agents can affect morphine-induced conditioned place preference (CPP). Effects of repeated intra-CA1 injections of dopamine (DA) receptor agonists and antagonists on morphine-induced CPP in rats were investigated using an unbiased 3-day schedule of place conditioning. Animals receiving once-daily subcutaneous (s.c.) injections of morphine (1-9 mg/kg) or saline (1.0 ml/kg, s.c.) showed a significant place preference in a dose-dependent manner: the maximum response was observed with 3 mg/kg morphine. Three days' intra-CA1 injections of apomorphine (0.25-1 mug/rat) followed by 5 days free of the drug, significantly decreased morphine CPP (1 and 3 mg/kg, s.c.). Moreover, pre-treatment with the highest dose of apomorphine (1 mug/rat) altered the effect of morphine to an aversive response. The morphine (1 and 3 mg/kg) CPP was also significantly decreased in animals that previously received three intra-CA1 injections of SKF 38393 (2-9 mug/rat), quinpirole (1-3 mug/rat) or sulpiride (1-3 mug/rat), and significantly increased in animals that had previously received three intra-CA1 injections of SCH 23390 (0.02 mug/rat). The 3-day pre-treatment with apomorphine, SKF 38393 or quinpirole reduced locomotor activity in the test session, while SCH 23390 and sulpiride did not have any influence on locomotor activity. It is concluded that repeated injections of DA receptor agents in the dorsal hippocampus, followed by 5 days free of the drugs, can affect morphine reward.


Download TeX format
back to top
scroll left or right